Investors Snatch IOVA 7.5% Lower Than Its Secondary Stock Offering
January 17, 2019 at 15:12 PM EST
Looking back to 97 days ago, Iovance Biotherapeutics Inc (IOVA) priced a 22,000,000 share secondary stock offering at $9.97 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..